Carcinogenesis, Vol 18, 2403-2414, Copyright © 1997 by Oxford University Press
SB Verghis, JM Essigmann, FF Kadlubar, ML Morningstar and DD Lasko
Mutagenesis by the human bladder carcinogen 4-aminobiphenyl (ABP) was
studied in single-stranded DNA from a bacteriophage M13 cloning vector. In
comparison to ABP lesions in double-stranded DNA, lesions in single-
stranded DNA were approximately 70-fold more mutagenic and 50-fold more
genotoxic. Sequencing analysis of ABP-induced mutations in the lacZ gene
revealed exclusively base-pair substitutions, with over 80% of the
mutations occurring at G sites; the G at position 6310 accounted for 25% of
the observed mutations. Among the sequence changes at G sites, G- ->T
transversions predominated, followed by G-->C transversions and G--
>A transitions. In order to further elucidate the mutagenic mechanism of
ABP, an oligonucleotide containing the major DNA adduct, N-
(deoxyguanosin-8-yl)-4-aminobiphenyl (dG(8-ABP)), was situated within the
PstI site of a single-stranded M13 genome. After in vivo replication of the
adduct containing ABP-modified and control (unadducted) genomes, the
mutational frequency and mutational specificity of the dG(8-ABP) lesion
were determined. The targeted mutational efficiency was approximately
0.01%, and the primary mutation observed was the G-->C transversion.
Thus dG(8-ABP), albeit weakly mutagenic at the PstI site, can contribute to
the mutational spectrum of ABP lesions.
ARTICLES
Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G-->C transversions at a unique dG(8-ABP) lesion in single-stranded DNA
Department of Chemistry, Whitaker College of Health Sciences, Massachusetts Institute of Technology, Cambridge 02139, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Besaratinia, S. E. Bates, and G. P. Pfeifer Mutational Signature of the Proximate Bladder Carcinogen N-Hydroxy-4-acetylaminobiphenyl: Inconsistency with the p53 Mutational Spectrum in Bladder Cancer Cancer Res., August 1, 2002; 62(15): 4331 - 4338. [Abstract] [Full Text] [PDF] |
||||
